Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Systemic Lupus Erythematosus
Trial Locations (33)

Unknown

RECRUITING

Research Site, Barnaul

RECRUITING

Research Site, Belgorod

RECRUITING

Research Site, Chelyabinsk

RECRUITING

Research Site, Grozny

RECRUITING

Research Site, Irkutsk

RECRUITING

Research Site, Izhevsk

RECRUITING

Research Site, Kaliningrad

RECRUITING

Research Site, Kazan'

RECRUITING

Research Site, Kemerovo

WITHDRAWN

Research Site, Kirov

RECRUITING

Research Site, Krasnodar

RECRUITING

Research Site, Makhachkala

RECRUITING

Research Site, Moscow

RECRUITING

Research Site, Murmansk

RECRUITING

Research Site, Nizny Novgorod

RECRUITING

Research Site, Novosibirsk

RECRUITING

Research Site, Omsk

RECRUITING

Research Site, Orenburg

RECRUITING

Research Site, Penza

RECRUITING

Research Site, Perm

RECRUITING

Research Site, Petrozavodsk

RECRUITING

Research Site, Ryazan

RECRUITING

Research Site, Saint-Petrburg

RECRUITING

Research Site, Samara

RECRUITING

Research Site, Saransk

RECRUITING

Research Site, Saratov

RECRUITING

Research Site, Surgut

RECRUITING

Research Site, Tula

RECRUITING

Research Site, Ufa

RECRUITING

Research Site, Ulyanovsk

RECRUITING

Research Site, Volgograd

RECRUITING

Research Site, Yaroslavl

RECRUITING

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT06759519 - Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia | Biotech Hunter | Biotech Hunter